Venture Visionary Partners LLC decreased its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 50.5% in the 1st quarter, according to its most recent 13F filing with the SEC. The firm owned 3,539 shares of the medical equipment provider's stock after selling 3,609 shares during the quarter. Venture Visionary Partners LLC's holdings in Intuitive Surgical were worth $1,753,000 at the end of the most recent quarter.
Other large investors have also added to or reduced their stakes in the company. Castleark Management LLC boosted its stake in Intuitive Surgical by 3.4% in the 4th quarter. Castleark Management LLC now owns 90,469 shares of the medical equipment provider's stock worth $47,221,000 after purchasing an additional 2,990 shares during the period. Arlington Trust Co LLC boosted its stake in Intuitive Surgical by 34.5% in the 1st quarter. Arlington Trust Co LLC now owns 745 shares of the medical equipment provider's stock worth $369,000 after purchasing an additional 191 shares during the period. Aveo Capital Partners LLC boosted its stake in Intuitive Surgical by 37.4% in the 1st quarter. Aveo Capital Partners LLC now owns 727 shares of the medical equipment provider's stock worth $390,000 after purchasing an additional 198 shares during the period. Aaron Wealth Advisors LLC boosted its stake in Intuitive Surgical by 3.2% in the 1st quarter. Aaron Wealth Advisors LLC now owns 2,509 shares of the medical equipment provider's stock worth $1,243,000 after purchasing an additional 78 shares during the period. Finally, Longbow Finance SA boosted its stake in Intuitive Surgical by 132.0% in the 1st quarter. Longbow Finance SA now owns 19,699 shares of the medical equipment provider's stock worth $9,756,000 after purchasing an additional 11,209 shares during the period. Institutional investors own 83.64% of the company's stock.
Intuitive Surgical Stock Up 1.3%
Shares of NASDAQ ISRG traded up $6.28 during trading hours on Friday, reaching $476.16. 2,023,902 shares of the stock traded hands, compared to its average volume of 1,973,062. The company has a market capitalization of $170.69 billion, a P/E ratio of 66.41, a price-to-earnings-growth ratio of 4.92 and a beta of 1.59. Intuitive Surgical, Inc. has a 52-week low of $425.00 and a 52-week high of $616.00. The company's 50-day simple moving average is $504.42 and its two-hundred day simple moving average is $522.06.
Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last announced its quarterly earnings data on Tuesday, July 22nd. The medical equipment provider reported $2.19 earnings per share for the quarter, beating analysts' consensus estimates of $1.93 by $0.26. The company had revenue of $2.44 billion for the quarter, compared to analysts' expectations of $2.35 billion. Intuitive Surgical had a return on equity of 14.56% and a net margin of 28.51%.Intuitive Surgical's revenue for the quarter was up 21.4% compared to the same quarter last year. During the same period last year, the firm posted $1.78 EPS. As a group, sell-side analysts forecast that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current fiscal year.
Analyst Upgrades and Downgrades
Several research analysts have commented on ISRG shares. UBS Group raised their target price on Intuitive Surgical from $547.00 to $585.00 and gave the stock a "neutral" rating in a research note on Wednesday, July 23rd. Deutsche Bank Aktiengesellschaft downgraded Intuitive Surgical from a "hold" rating to a "sell" rating and dropped their price target for the company from $515.00 to $440.00 in a research report on Monday, June 9th. Piper Sandler reiterated an "overweight" rating and set a $595.00 price target (up previously from $575.00) on shares of Intuitive Surgical in a research report on Wednesday, July 23rd. Truist Financial lifted their price target on Intuitive Surgical from $590.00 to $600.00 and gave the company a "buy" rating in a research report on Wednesday, July 23rd. Finally, Erste Group Bank reiterated a "hold" rating on shares of Intuitive Surgical in a research report on Wednesday, July 23rd. Thirteen research analysts have rated the stock with a Buy rating, six have issued a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat.com, the stock currently has a consensus rating of "Moderate Buy" and an average target price of $595.95.
Check Out Our Latest Analysis on ISRG
Insider Activity at Intuitive Surgical
In other Intuitive Surgical news, EVP Myriam Curet sold 4,500 shares of Intuitive Surgical stock in a transaction that occurred on Friday, July 25th. The stock was sold at an average price of $492.48, for a total value of $2,216,160.00. Following the transaction, the executive vice president directly owned 353 shares of the company's stock, valued at $173,845.44. The trade was a 92.73% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, insider Gary S. Guthart sold 7,893 shares of Intuitive Surgical stock in a transaction that occurred on Monday, July 28th. The stock was sold at an average price of $498.64, for a total value of $3,935,765.52. Following the completion of the transaction, the insider directly owned 13,187 shares in the company, valued at $6,575,565.68. This trade represents a 37.44% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders have sold 15,839 shares of company stock valued at $7,896,972. Corporate insiders own 0.70% of the company's stock.
Intuitive Surgical Profile
(
Free Report)
Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.
See Also

Before you consider Intuitive Surgical, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Intuitive Surgical wasn't on the list.
While Intuitive Surgical currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.